ClinicalTrials.gg
RecruitingNCT06226272COMPASSUpdated Jun 26, 2026

Clinical Outcome Measure at Stryker Spine

An observational study in Degenerative Disc Disease and Degenerative Scoliosis, sponsored by VB Spine, LLC. Recruiting at 7 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-26.

Sponsored by VB Spine, LLC · Observational

How we know

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
5,222
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 232 studies in Intervertebral Disc Degeneration with a site in United States — 41 open to participants now, 58 under way, 5 of them phase 3. Intervertebral Disc Degeneration · United States.

Planned enrollment
Largest of 91
5,222 · median 118
Started
2025
with 8 others
Observational
91 of 232
19 open now
Primary completion
2029-01
later than 49 of 57 live
Registered
210th of 232
by date

Among the 232 studies in Intervertebral Disc Degeneration with a site in United States, this one has the largest planned enrollment of the 91 observational ones that give a count, is one of 9 that started in 2025, is one of 91 observational ones, reaches primary completion later than 49 of the 57 other live ones, and was the 210th registered.

Intervertebral Disc Degeneration

462 studies on the registry are indexed under Intervertebral Disc Degeneration; 100 are open to participants now.

Browse Intervertebral Disc Degeneration studies →

Open to participants now

41 of the 232 studies in Intervertebral Disc Degeneration with a site in United States are open now. Recruiting first, the newest first:

35 more — sign in →

All 41 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 60 Intervertebral Disc Degeneration studies recruiting now, 29 (48%) set no upper age limit and 16 (27%) stop at 75 or younger; 7 take children under 18; 5 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 232 studies in Intervertebral Disc Degeneration with a site in United States, or all of them as a file.
02

Study summary

This is a multicenter, prospective, retrospective, Post Market Clinical Follow-up (PMCF) study in subjects who have undergone or will undergo surgery utilizing one or more Stryker devices according to Stryker cleared Instructions for Use (IFU).

Read the detailed description

Stryker Spine has a broad portfolio of spinal devices used to stabilize the spine. This PMCF study is designed to collect data on the performance and safety of the devices over their lifetime of 24 months post-implantation. Four protocols have been designed to aid in this process, a master and three sub-protocols. The sub-protocols are based on body region and indication:

  • S-S-102-A Cervical: Interbody Devices (IBDs), Vertebral Body Replacement Devices (VBRs), Internal Fixation Devices, and Vitoss
  • S-S-102-B Thoracolumbar: IBDs, VBRs, Internal Fixation Devices, and Vitoss
  • S-S-102-C Adult Spinal Deformities: IBDs, Internal Fixation Devices, and Vitoss Each of the sub-protocols has its own specific performance endpoint and hypothesis, radiographical data assessments, and SAPs. Safety data will be collected throughout the study.
03

Conditions studied

  • Degenerative Disc Disease
  • Degenerative Scoliosis

Keywords

  • Device: Cervical or Thoracolumbar Spinal fusion
  • Device: Adult Spinal Deformities
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population includes subjects who have undergone or will undergo surgery utilizing one or more Stryker devices according to Stryker cleared IFUs and Surgical Technique Guides (STGs) by a participating investigator and are willing to complete the following patient-reported outcome measures (PROMs) at the study-specific time points.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • To be eligible to participate in the study, the potential subject must meet all inclusion criteria specific to the Stryker system being evaluated, please contact one of the participating investigators or see the device-specific cleared IFU, for further details.

Exclusion criteria

Exclusion Criteria:

  • The exclusion criteria are based on the as presented in the Stryker device cleared IFUs, please contact one of the participating investigators or see the device-specific cleared IFU, for further details.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
5,222 participants (estimated)
Patient registry
No

Groups and cohorts

  • S-S-102-A: Cervical Sub-Protocol

    The study population includes subjects who are surgically treated with a Stryker device for a cervical condition per the specific device cleared IFUs and Surgical Technique Guides (STGs), by a participating investigator and are willing to complete patient-reported questionnaires at the study-specific time points.

    Device: Spinal Fusion

  • S-S-102-B: Thoracolumbar Sub-Protocol

    The study population includes subjects who are surgically treated with a Stryker device for a thoracic/lumbar condition per the specific device cleared IFUs and STGs, by a participating investigator and are willing to complete patient-reported questionnaires at the study-specific time points.

    Device: Spinal Fusion

  • S-S-102-C: Adult Spinal Deformities

    The study population includes subjects who are surgically treated with a Stryker device for a spinal deformity condition per the specific device cleared IFUs and STGs, by a participating investigator and are willing to complete patient-reported questionnaires at the study-specific time points.

    Device: Spinal Deformities Correction

Interventions

  • DeviceSpinal Fusion

    Cervical Spinal Fusion

  • DeviceSpinal Fusion

    Thoracic / Lumbar Spinal Fusion

  • DeviceSpinal Deformities Correction

    Spinal Deformities Correction

06

What researchers measure

Primary outcomes

  1. S-S-102-A

    Mean change in the subject's Neck Disability Index (NDI) score.

    Time frame: Baseline through 24-months post-op.

  2. S-S-102-B

    Mean change in the subject's Oswestry Disability Index (ODI) score.

    Time frame: Baseline through 24-months post-op.

  3. S-S-102-C

    Mean change in the subject's Scoliosis Research Society-22 revised (SRS-22r).

    Time frame: Baseline through 24-months post-op.

Secondary outcomes

  1. S-S-102-A

    The incidence of the following safety events: * Serious Adverse Events (AEs) * Device-related AEs * Procedure-related AEs * Operative AEs * Secondary spine surgeries

    Time frame: Surgery through 24-months post-op.

  2. S-S-102-B

    The incidence of the following safety events: * Serious Adverse Events (AEs) * Device-related AEs * Procedure-related AEs * Operative AEs * Secondary spine surgeries

    Time frame: Surgery through 24-months post-op.

  3. S-S-102-C

    The incidence of the following safety events: * Serious Adverse Events (AEs) * Device-related AEs * Procedure-related AEs * Operative AEs * Secondary spine surgeries

    Time frame: Surgery through 24-months post-op.

07

Study locations

7 of 7 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Jan 2029, 48 months after the start.

Of 80 observational studies under Intervertebral Disc Degeneration, half reached primary completion within 61 months of starting (the median), counting those still running; a quarter within 45 and three quarters within 84. This study's planned 48 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 4, 2024
First posted
Jan 26, 2024
StartActual
Jan 28, 2025
Primary completionEst.
Jan 29, 2029
CompletionEst.
Jan 29, 2032
Last update
Jun 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06226272
Lead sponsor
VB Spine, LLC
Responsible party
Sponsor
First posted
Jan 26, 2024
Start date
Jan 28, 2025
Primary completion
Jan 29, 2029 (estimated)
Completion
Jan 29, 2032 (estimated)
Last update
Jun 26, 2026

Study contacts

Mary Majer
Contact
mary.majer@vbspineco.com
866-526-4171
Effa Gyamfi
Contact
effa.gyamfi@vbspineco.com
866-526-4171
Jad G. Khalil, MD
principal investigator · Michigan Orthopaedic Surgeons

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion